Patents by Inventor Lieve Nuytinck

Lieve Nuytinck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING THE RISK OF DEVELOPING A NEUROLOGICAL DISEASE
    Publication number: 20120208185
    Abstract: Methods and kits are provided for determining whether a subject is at risk of developing a neurological disease such as Alzheimer's disease and multiple sclerosis. The methods and kits are based on the detection of one or more nucleic acid variants in the MBL gene of the subject.
    Type: Application
    Filed: November 21, 2011
    Publication date: August 16, 2012
    Inventors: Eugeen Van Mechelen, Lieve Nuytinck
  • Method for determining the risk of developing a neurological disease
    Patent number: 8062842
    Abstract: Methods and kits are provided for determining whether a subject is at risk of developing a neurological disease such as Alzheimer's disease and multiple sclerosis. The methods and kits are based on the detection of one or more nucleic acid variants in the MBL gene of the subject.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: November 22, 2011
    Assignee: Abbott Healthcare Products B.V.
    Inventors: Eugeen Vanmechelen, Lieve Nuytinck
  • MARKERS FOR THE PROGNOSIS OF LUNG FUNCTION AND COLONIZATION WITH AN INFECTIOUS AGENT
    Publication number: 20110020803
    Abstract: The present invention provides a method and kit for determining the risk for impaired lung function and/or the susceptibility for colonization with an infectious agent. The method and kit comprise determining the presence or absence of one or more nucleic acid variants in a gene or a combination of genes.
    Type: Application
    Filed: September 29, 2008
    Publication date: January 27, 2011
    Inventors: Lieve Nuytinck, Els De Meester
  • Method for determining the risk of developing a neurological disease
    Publication number: 20080261889
    Abstract: Methods and kits are provided for determining whether a subject is at risk of developing a neurological disease such as Alzheimer's disease and multiple sclerosis. The methods and kits are based on the detection of one or more nucleic acid variants in the MBL gene of the subject.
    Type: Application
    Filed: June 10, 2008
    Publication date: October 23, 2008
    Inventors: Eugeen Vanmechelen, Lieve Nuytinck
  • Method for determining the risk of developing a neurological disease
    Publication number: 20050191685
    Abstract: Methods and kits are provided for determining whether a subject is at risk of developing a neurological disease such as Alzheimer's disease and multiple sclerosis. The methods and kits are based on the detection of one or more nucleic acid variants in the MBL gene of the subject.
    Type: Application
    Filed: February 23, 2005
    Publication date: September 1, 2005
    Inventors: Eugeen Vanmechelen, Lieve Nuytinck